BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26206944)

  • 1. Balancing bleeding in brain metastases.
    Kreuziger LB
    Blood; 2015 Jul; 126(4):432-3. PubMed ID: 26206944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study.
    Donato J; Campigotto F; Uhlmann EJ; Coletti E; Neuberg D; Weber GM; Zwicker JI
    Blood; 2015 Jul; 126(4):494-9. PubMed ID: 25987658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors.
    Carney BJ; Uhlmann EJ; Puligandla M; Mantia C; Weber GM; Neuberg DS; Zwicker JI
    J Thromb Haemost; 2019 Jan; 17(1):72-76. PubMed ID: 30450803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracranial hemorrhage in cancer patients treated with anticoagulation.
    Weinstock MJ; Uhlmann EJ; Zwicker JI
    Thromb Res; 2016 Apr; 140 Suppl 1():S60-5. PubMed ID: 27067980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin.
    Mantia C; Uhlmann EJ; Puligandla M; Weber GM; Neuberg D; Zwicker JI
    Blood; 2017 Jun; 129(25):3379-3385. PubMed ID: 28468796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation in the Setting of Primary and Metastatic Brain Tumors.
    Mantia C; Zwicker JI
    Cancer Treat Res; 2019; 179():179-189. PubMed ID: 31317488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases.
    Alvarado G; Noor R; Bassett R; Papadopoulos NE; Kim KB; Hwu WJ; Bedikian A; Patel S; Hwu P; Davies MA
    Melanoma Res; 2012 Aug; 22(4):310-5. PubMed ID: 22584956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation.
    Zwicker JI; Karp Leaf R; Carrier M
    J Thromb Haemost; 2016 Sep; 14(9):1736-40. PubMed ID: 27306689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The balance of risk of bleeding and thrombosis in melanoma patients with brain metastases.
    Uchino K
    Melanoma Res; 2013 Feb; 23(1):82. PubMed ID: 23196331
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of intracranial hemorrhage associated with therapeutic anticoagulation for venous thromboembolism in cancer patients: a systematic review and meta-analysis.
    Rojas-Hernandez CM; Oo TH; García-Perdomo HA
    J Thromb Thrombolysis; 2017 Feb; 43(2):233-240. PubMed ID: 27704333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of long-term anticoagulation in patients with brain metastases.
    Horstman H; Gruhl J; Smith L; Ganti AK; Shonka NA
    Med Oncol; 2018 Mar; 35(4):43. PubMed ID: 29497873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low molecular weight heparin administration in cancer patients with hypercoagulability-related complications and carrying brain metastases: a case series study.
    Vitale FV; Rotondo S; Sessa E; Parisi A; Giaimo V; D'Angelo A; Antonelli G; Romeo P; Ferraù F
    J Oncol Pharm Pract; 2012 Mar; 18(1):10-6. PubMed ID: 21228085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: A meta-analysis.
    Porfidia A; Giordano M; Sturiale CL; D'Arrigo S; Donadini MP; Olivi A; Ageno W; Pola R
    Brain Behav; 2020 Jun; 10(6):e01638. PubMed ID: 32314875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of low-molecular-weight heparin treatment for venous thromboembolism in patients with primary and metastatic brain tumours.
    Chai-Adisaksopha C; Linkins LA; ALKindi SY; Cheah M; Crowther MA; Iorio A
    Thromb Haemost; 2017 Feb; 117(3):589-594. PubMed ID: 28078351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Anticoagulation in Patients with Primary Brain Tumors or Secondary Brain Metastasis.
    Lin RJ; Green DL; Shah GL
    Oncologist; 2018 Apr; 23(4):468-473. PubMed ID: 29158366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous Thrombotic Events and Anticoagulation in Brain Tumor Patients.
    Diaz M; Jo J
    Curr Oncol Rep; 2022 Apr; 24(4):493-500. PubMed ID: 35179708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thrombosis in patients with high-grade glioma.
    Taillibert S; Taillandier L; Le Rhun E
    Curr Opin Oncol; 2015 Nov; 27(6):516-21. PubMed ID: 26447877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of malignancy-associated venous thromboembolism among patients treated with rivaroxaban compared to enoxaparin.
    Nicklaus MD; Ludwig SL; Kettle JK
    J Oncol Pharm Pract; 2018 Apr; 24(3):185-189. PubMed ID: 29284351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical venous thromboembolism prophylaxis in neurosurgical patients: an updated systematic review and meta-analysis.
    Khan NR; Patel PG; Sharpe JP; Lee SL; Sorenson J
    J Neurosurg; 2018 Oct; 129(4):906-915. PubMed ID: 29192859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in anticoagulation for patients with brain tumors.
    Iyengar V; Patell R; Zwicker J
    Best Pract Res Clin Haematol; 2022 Mar; 35(1):101350. PubMed ID: 36030073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.